2004 News Archive


12/3/2004 Adherex Completes Acquisition of Cadherin Biomedical
11/12/2004 Adherex Reports 1Q05 Financial Results
11/10/2004 Adherex Receives Approval for AMEX Listing
11/8/2004 Adherex Updates Exherin Phase I Trial Data and Reports Evidence of Anti-Tumor Activity
10/25/2004 Adherex to Webcast Presentation at Rodman & Renshaw Conference
10/13/2004 Adherex Names Former GlaxoSmithKline Research Executive As Chief Scientific Officer
10/11/2004 Adherex Establishes Satellite Location In Ottawa For Its Annual Shareholders Meeting
10/4/2004 Adherex Issued Patent For Method Of Improving Drug Delivery To Tumors
9/20/2004 Adherex reports 2004 Year End results
9/16/2004 Adherex Files Registration Statement With SEC
9/13/2004 Adherex Presents At Orion Securities Healthcare Conference
9/7/2004 Adherex Names Chief Medical Officer
8/30/2004 Adherex further strengthens patent protection for novel approach to cancer therapy
7/28/2004 Adherex To Reacquire Cadherin Biomedical Inc.
7/9/2004 Adherex Responds To Cadherin Biomedical Counterclaim
7/8/2004 Adherex Conference Call Details
7/7/2004 Adherex Appoints Harvard Medical School Professor To Advisory Committee
7/6/2004 Adherex Obtains Investigational New Drug (IND) Clearance From U.S. FDA For Exherin™
6/7/2004 Adherex Releases Initial Exherin™ Clinical Data At ASCO
5/26/2004 Adherex Technologies Reports Third Quarter 2004 Results
5/25/2004 Peter Karmanos, Jr. Appointed To Adherex Board Of Directors
5/20/2004 Adherex Completes Financings For $12.4 Million
5/5/2004 Adherex files preliminary short form prospectus
5/3/2004 Adherex announces $4.2 Million "Bought Deal"
4/26/2004 Adherex Announces New Chief Financial Officer
4/23/2004 Adherex Expands Patent Protection For Drug Delivery To Tumors
4/13/2004 Adherex appoints scientific and clinical advisory committee
3/24/2004 Adherex Receives FDA Orphan Drug Designation For STS
3/2/2004 Adherex Announces Board Changes
2/25/2004 Adherex Technologies Reports Second Quarter Results
1/27/2004 Adherex Issued Cancer Diagnostics Patent
1/21/2004 Adherex Further Expands Patent Protection In Oncology